Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2012-09-24

Clinical Trial Update: Effectiveness of Amantadine Hydrochloride for Treatment of Severe Traumatic Brain Injury (TBI) [Phase 2, Phase 3]

View source ↗

Summary

An update on a Phase 2/Phase 3 trial evaluating amantadine hydrochloride for severe traumatic brain injury. The trial results were posted in 2012.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • amantadine hydrochloride (amantadine hydrochloride)

Snippet

Sponsor: JFK Medical Center | Conditions: Traumatic Brain Injury | Phase 2, Phase 3 | Status: COMPLETED | Results posted: 2012-09-24